Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain

被引:41
作者
Rodriguez, D. [1 ]
Almirante, B. [1 ]
Cuenca-Estrella, M. [2 ]
Rodriguez-Tudela, J. L. [2 ]
Mensa, J. [3 ]
Ayats, J. [4 ]
Sanchez, F. [5 ]
Pahissa, A. [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Div Infect Dis, Barcelona 08035, Spain
[2] Inst Salud Carlos III, Dept Mycol, Madrid, Spain
[3] IDIBAPS, Hosp Clin, Div Infect Dis, Barcelona, Spain
[4] Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain
[5] Hosp Santa Cruz & St Pau, Dept Microbiol, Barcelona, Spain
关键词
Candida albicans; candidaemia; non-albicans candida spp; predictors; prognosis; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; IN-VITRO SUSCEPTIBILITIES; ANTIFUNGAL AGENTS; RISK-FACTORS; INTERNATIONAL SURVEILLANCE; NATIONAL SURVEILLANCE; EPIDEMIOLOGY; PROGRAM; FLUCONAZOLE;
D O I
10.1111/j.1469-0691.2010.03208.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
P>Although Candida albicans (CA) is the most common cause of Candida bloodstream infections (BSIs), recent studies have observed an increasing percentage of candidaemias caused by non-albicans Candida species (NAC). In the present study, we attempted to identify the predictors of candidaemia due to NAC compared to CA. We analyzed data from an active population-based surveillance in Barcelona (Spain) from January 2002 to December 2003. Factors associated with NAC fungaemia were determined by multivariate analysis. A total of 339 episodes of Candida BSI, in 336 patients (median age 63 years, interquartile range: 41-72 years), were included. CA was the most commonly isolated (52%), followed by Candida parapsilosis (23%), Candida tropicalis (10%), Candida glabrata (8.6%), Candida krusei (3.4%) and other NAC spp. (3%).Overall, 48% of cases were due to NAC spp. Multivariate logistic regression analysis identified factors associated with a risk of BSI due to NAC spp.: having received a haematologic transplant (OR 10.8; 95% CI 1.31-90.01; p 0.027), previous fluconazole exposure (OR 4.47; 95% CI 2.12-9.43; p < 0.001) and neonatal age (OR 4.42; 95% CI 1.63-12.04; p 0.004). Conversely, previous CA colonization (OR 0.33; 95% CI 0.19-0.57; p 0.001) and previous antibiotic use (OR 0.42; 95% CI 0.21-0.85; p 0.017) were associated with CA fungaemia compared to NAC. In conclusion, NAC candidaemia comprised 48% of cases in our series. Predictors of NAC include having received a haematologic transplant, neonatal age and previous fluconazole use.
引用
收藏
页码:1676 / 1682
页数:7
相关论文
共 35 条
[1]   Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 [J].
Almirante, B ;
Rodríguez, D ;
Park, BJ ;
Cuenca-Estrella, M ;
Planes, AM ;
Almela, M ;
Mensa, J ;
Sanchez, F ;
Ayats, J ;
Gimenez, M ;
Saballs, P ;
Fridkin, SK ;
Morgan, J ;
Rodriguez-Tudela, JL ;
Warnock, DW ;
Pahissa, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) :1829-1835
[2]   Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections:: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003 [J].
Almirante, Benito ;
Rodríguez, Dolors ;
Cuenca-Estrella, Manuel ;
Almela, Manel ;
Sanchez, Ferran ;
Ayats, Josefina ;
Alonso-Tarres, Carles ;
Rodriguez-Tudela, Juan L. ;
Pahissa, Albert .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (05) :1681-1685
[3]   Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility [J].
Arendrup, M. C. ;
Fuursted, K. ;
Gahrn-Hansen, B. ;
Schonheyder, H. C. ;
Knudsen, J. D. ;
Jensen, I. M. ;
Bruun, B. ;
Christensen, J. J. ;
Johansen, H. K. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (05) :487-494
[4]   Epidemiological trends in nosocomial candidemia in intensive care [J].
Bassetti, M ;
Righi, E ;
Costa, A ;
Fasce, R ;
Molinari, MP ;
Rosso, R ;
Pallavicini, FB ;
Viscoli, C .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[5]   Effect of fluconazole consumption on long-term trends in candidal ecology [J].
Blot, S. ;
Janssens, R. ;
Claeys, G. ;
Hoste, E. ;
Buyle, F. ;
De Waele, J. J. ;
Peleman, R. ;
Vogelaers, D. ;
Vandewoude, K. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) :474-477
[6]   The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer [J].
Bodey, GP ;
Mardani, M ;
Hanna, HA ;
Boktour, M ;
Abbas, J ;
Girgawy, E ;
Hachem, RY ;
Kontoyiannis, DP ;
Raad, II .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (05) :380-385
[7]   PREDICTING OUTCOME AMONG INTENSIVE-CARE UNIT PATIENTS USING COMPUTERIZED TREND ANALYSIS OF DAILY APACHE-II SCORES CORRECTED FOR ORGAN SYSTEM FAILURE [J].
CHANG, RWS ;
JACOBS, S ;
LEE, B .
INTENSIVE CARE MEDICINE, 1988, 14 (05) :558-566
[8]   Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? [J].
Charlier, C ;
Hart, E ;
Lefort, A ;
Ribaud, P ;
Dromer, F ;
Denning, DW ;
Lortholary, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) :384-410
[9]   Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit [J].
Chow, Jennifer K. ;
Golan, Yoav ;
Ruthazer, Robin ;
Karchmer, Adolf W. ;
Carmeli, Yehuda ;
Lichtenberg, Deborah ;
Chawla, Varun ;
Young, Janet ;
Hadley, Susan .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) :1206-1213
[10]   In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents:: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003 [J].
Cuenca-Estrella, M ;
Rodriguez, D ;
Almirante, B ;
Morgan, J ;
Planes, AM ;
Almela, M ;
Mensa, J ;
Sanchez, F ;
Ayats, J ;
Gimenez, M ;
Salvado, M ;
Warnock, DW ;
Pahissa, A ;
Rodriguez-Tudela, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (02) :194-199